Clinical Trial Update: Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for adalimumab in adult Japanese patients with rheumatoid arthritis. Results were posted in January 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: Abbott | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2010-01-13